NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,106 | -10.2% | 10,650 | -7.9% | 0.00% | – |
| Q2 2023 | $85,891 | +74.8% | 11,560 | +63.0% | 0.00% | – |
| Q1 2023 | $49,148 | -1.7% | 7,092 | +45.8% | 0.00% | – |
| Q4 2022 | $49,991 | -23.1% | 4,863 | +36.4% | 0.00% | – |
| Q3 2022 | $65,000 | -58.6% | 3,565 | +16.5% | 0.00% | – |
| Q2 2022 | $157,000 | -96.6% | 3,059 | -95.2% | 0.00% | – |
| Q1 2022 | $4,674,000 | -83.5% | 63,469 | -68.0% | 0.00% | -100.0% |
| Q4 2021 | $28,363,000 | -90.6% | 198,245 | -86.4% | 0.00% | -91.7% |
| Q3 2021 | $303,068,000 | -70.8% | 1,461,909 | -70.1% | 0.02% | -70.4% |
| Q2 2021 | $1,037,178,000 | +19.4% | 4,885,203 | +2.0% | 0.08% | +9.5% |
| Q1 2021 | $868,639,000 | +345.0% | 4,790,910 | +173.7% | 0.07% | +335.3% |
| Q4 2020 | $195,210,000 | +67.5% | 1,750,608 | +62.7% | 0.02% | +41.7% |
| Q3 2020 | $116,577,000 | +75599.4% | 1,075,933 | +58121.5% | 0.01% | – |
| Q2 2020 | $154,000 | – | 1,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |